Search research articles
Contact Us
Filters
Showing results (261-270 of 7,541) with videos related to
Page
of 755
Sort By:
Nature Biotechnology
|
April 9, 2008
Can 'double blockbuster' strengthen Amgen's backbone?
Cormac Sheridan
Nature Biotechnology
|
October 12, 2016
Surprise rejection for Amgen's D-peptide
Cormac Sheridan
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 12, 2017
Five hand hygiene elements may be useful audit tools
Lis Sheridan
Animal Behaviour
|
December 16, 1998
Female choice for spot asymmetry in the Trinidadian guppy
Sheridan, Pomiankowski
The Journal of Comparative Medicine and Veterinary Archives
|
November 17, 2022
Tuberculous Infection through the Alimentary Canal
Sheridan Delapine
Nature Biotechnology
|
February 15, 2023
Industry appetite for natural killer cells intensifies
Cormac Sheridan
Nature Biotechnology
|
August 9, 2012
Cautious optimism surrounds early clinical data for PD-1 blocker
Cormac Sheridan
Nature Biotechnology
|
November 10, 2012
Calamitous HCV trial casts shadow over nucleoside drugs
Cormac Sheridan
Nature Biotechnology
|
February 7, 2015
Pivotal trials for β-secretase inhibitors in Alzheimer's
Cormac Sheridan
Nature Biotechnology
|
October 14, 2025
Big pharma seduced by transcription factors again. What has changed?
Cormac Sheridan
Page
of 755
Search research articles
Search
Showing results (261-270 of 7,541) with videos related to
Sort By:
Page
of 755
Nature Biotechnology
|
April 9, 2008
Can 'double blockbuster' strengthen Amgen's backbone?
Cormac Sheridan
Nature Biotechnology
|
October 12, 2016
Surprise rejection for Amgen's D-peptide
Cormac Sheridan
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|
January 12, 2017
Five hand hygiene elements may be useful audit tools
Lis Sheridan
Animal Behaviour
|
December 16, 1998
Female choice for spot asymmetry in the Trinidadian guppy
Sheridan, Pomiankowski
The Journal of Comparative Medicine and Veterinary Archives
|
November 17, 2022
Tuberculous Infection through the Alimentary Canal
Sheridan Delapine
Nature Biotechnology
|
February 15, 2023
Industry appetite for natural killer cells intensifies
Cormac Sheridan
Nature Biotechnology
|
August 9, 2012
Cautious optimism surrounds early clinical data for PD-1 blocker
Cormac Sheridan
Nature Biotechnology
|
November 10, 2012
Calamitous HCV trial casts shadow over nucleoside drugs
Cormac Sheridan
Nature Biotechnology
|
February 7, 2015
Pivotal trials for β-secretase inhibitors in Alzheimer's
Cormac Sheridan
Nature Biotechnology
|
October 14, 2025
Big pharma seduced by transcription factors again. What has changed?
Cormac Sheridan
Page
of 755